Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide
Quanterix Corporation (QTRX)
US:NASDAQ Investor Relations:
ir.quanterix.com/investor-relations
Company Research
Source: Business Wire
Collaboration Aims to Expand Access to Early Detection of Potential Disease Marker BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a partnership with Life Line Screening (LLS), a national organization focused on identifying asymptomatic risks for chronic conditions in community health settings. Through the partnership, Life Line Screening will offer Lucent’s non-invasive blood based biomarker test nationally, with programs in Florida, California, and Texas already underway. This partnership supports the goals of both organizations to provide non-invasive, easily accessible testing in the general public.According to the Alzheimer's Association, an estimated 7 million Americans are living with Alzheimer's disease today, with another 6-7 million experiencing symptoms of Mild Cognitive Impairment (MCI). These figures underscore the urgent public health need for scalable testing options that can facilitate earlier i
Show less
Read more
Impact Snapshot
Event Time:
QTRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QTRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QTRX alerts
High impacting Quanterix Corporation news events
Weekly update
A roundup of the hottest topics
QTRX
News
- Quanterix (QTRX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts [Yahoo! Finance]Yahoo! Finance
- Quanterix Corporation (QTRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Quanterix targets $169M–$174M 2026 revenue with focus on diagnostics and cost synergies [Seeking Alpha]Seeking Alpha
- Quanterix Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
QTRX
Earnings
- 3/2/26 - Miss
QTRX
Analyst Actions
- 12/22/25 - Canaccord Genuity
QTRX
Sec Filings
- 3/2/26 - Form 10-K
- 3/2/26 - Form 8-K
- 2/18/26 - Form 4
- QTRX's page on the SEC website